Alcohol withdrawal symptoms are the body's rebound reaction when alcohol, a central nervous system depressant, is removed after prolonged heavy drinking. They begin 6 to 24 hours after the last drink with tremor, anxiety, sweating, and nausea, peak between 24 and 72 hours, and can escalate to seizures or delirium tremens in roughly 3 to 5 percent of untreated cases. Most symptoms resolve within 5 to 7 days. Severity tracks daily intake, drinking duration, and prior withdrawal episodes, which is why clinicians stage every patient on a validated scale before deciding who needs medication.
What Causes Alcohol Withdrawal: The GABA Glutamate Imbalance
Alcohol binds GABA-A receptors, the brain's main inhibitory brake, and simultaneously suppresses NMDA glutamate receptors, the main accelerator. With chronic exposure, the brain adapts by down-regulating GABA-A receptor sensitivity and up-regulating NMDA receptor density. This adaptation keeps the nervous system functional while alcohol is present.
When drinking stops, the brake weakens and the accelerator stays pressed. The result is a hyperexcitable nervous system: tremor, sweating, tachycardia, and in severe cases seizures and delirium. In plain terms: the brain spent months rebalancing against alcohol, and removing the drug leaves that rebalancing running unopposed.
The autonomic surge is measurable. Blood pressure often rises 10 to 20 mmHg, heart rate climbs 10 to 30 beats per minute, and core temperature may drift upward. These are the same signs a stimulant would produce, which is why withdrawal is sometimes described as an internal overdose of excitatory signaling rather than the mere "absence" of alcohol.
Quantified Context: How Common and How Dangerous
Roughly half of people who drink heavily and stop abruptly will develop withdrawal symptoms, per the American Society of Addiction Medicine. About 10 percent of that group progress to withdrawal seizures, and 3 to 5 percent of untreated patients develop delirium tremens.
Delirium tremens carries real mortality without treatment. Before modern intensive care, death rates ran as high as 35 percent; with benzodiazepine treatment and supportive care, mortality falls to roughly 1 to 2 percent. The number that matters most for triage is the 3 to 5 percent figure, because it defines who needs monitored care rather than outpatient tapering.
Severity thresholds follow the CIWA-Ar scale, a 10-item scored assessment. A score of 8 or below indicates mild withdrawal managed with supportive care; 9 to 15 indicates moderate withdrawal where benzodiazepines are typically indicated; above 15 signals severe withdrawal requiring close monitoring. These thresholds are the practical anchor for every decision below.
Alcohol Withdrawal Timeline: Hour by Hour and Day by Day
The withdrawal course follows a predictable arc. Symptom onset, peak, and resolution vary by several hours between individuals, so treat the table as a range, not a schedule.
| Timeframe | Typical symptoms | Clinical concern |
|---|---|---|
| 6–12 hours | Tremor, anxiety, sweating, nausea, insomnia, mild hypertension | Low; monitor |
| 12–24 hours | Worsening tremor, tachycardia, sensory hypersensitivity, mild confusion | Rising; CIWA-Ar scoring begins |
| 24–48 hours | Peak autonomic symptoms, withdrawal seizures possible | High; seizure risk peaks here |
| 48–72 hours | Delirium tremens onset, hallucinosis, profound agitation | Critical; inpatient care |
| 72–96 hours | Delirium tremens peak severity if untreated | Critical; mortality risk highest |
| 5–7 days | Resolution of autonomic symptoms, improving sleep | Decreasing |
| 1–4 weeks | Protracted withdrawal: mood instability, anhedonia, sleep disturbance | Low acute risk; relapse window |
Notice the overlap: withdrawal seizures typically occur 24 to 48 hours after the last drink, while delirium tremens starts 48 to 72 hours out. A patient who seizes on day one can still develop delirium two days later, which is why seizure-free patients still need monitoring through the 72-hour window.
Mild vs Moderate vs Severe Withdrawal: Comparison Table
Staging determines care level. The side-by-side comparison below condenses what clinicians assess at each tier.
| Feature | Mild | Moderate | Severe / DTs |
|---|---|---|---|
| CIWA-Ar score | 0–8 | 9–15 | Above 15 |
| Onset | 6–12 hours | 12–48 hours | 48–96 hours |
| Tremor | Mild, constant | Marked | Coarse, disabling |
| Heart rate | Up to 100 bpm | 100–120 bpm | Above 120 bpm |
| Hallucinations | None | Possible | Visual and tactile |
| Seizures | Rare | Possible | High risk |
| Disorientation | None | Mild | Profound |
| Care setting | Outpatient taper | Outpatient with close follow-up | Inpatient monitored care |
| Benzodiazepines | Optional | Usually indicated | Required |
The hallucinosis subtype deserves a note. Alcoholic hallucinosis produces vivid auditory or visual hallucinations with a clear sensorium, meaning the patient is oriented and not confused. It occurs in roughly 5 to 10 percent of withdrawal episodes and carries a lower mortality than delirium tremens but a higher long-term relapse risk. Distinguishing the two matters because a confused hallucinating patient is a DTs emergency, while an oriented hallucinating patient is not.
Non-Obvious Details: Kindling and the Prior-Withdrawal Effect
Each withdrawal episode does not reset the system to baseline. Repeated episodes sensitize the brain, a phenomenon called kindling, so the second withdrawal is typically worse than the first and the fifth can be far more dangerous than the intake volume would suggest. A patient who drank 8 standard drinks daily for five years and withdraws for the first time may score 6 on CIWA-Ar; the same patient after three prior withdrawals may score 14 on identical intake.
This has a direct clinical consequence. A history of prior withdrawal seizures or prior DTs lowers the threshold for aggressive treatment regardless of current intake, and many protocols recommend prophylactic benzodiazepines for any patient with that history. It also corrects a common misconception: the newest patient is not always the sickest.
A second non-obvious point concerns baclofen and gabapentin. These are sometimes used as alternatives to benzodiazepines, particularly in liver disease, but evidence for their superiority is mixed and they are not first-line for severe withdrawal. The established science favors benzodiazepines for DTs; the hypothesis of "benzo-sparing" protocols remains under study.
Misconceptions and Edge Cases
The most persistent misconception is that withdrawal is primarily psychological. The autonomic signs, seizures, and DTs are all measurable physiologic events, and psychological symptoms are the least dangerous layer.
A second misconception is that symptoms are proportional to blood alcohol level at presentation. They are not. Symptom severity tracks the prior adaptation, not the current level, which is why a patient can present with a high level and minimal symptoms or a low level and severe tremor.
Edge cases matter. Patients with liver disease metabolize benzodiazepines slowly and may need shorter-acting agents. Pregnant patients require obstetric involvement because withdrawal carries fetal risk. Patients on high-dose opioids or sedative-hypnotics can experience overlapping withdrawal syndromes that mask or mimic alcohol withdrawal. Older adults show higher rates of DTs at lower intake levels, largely due to reduced hepatic reserve and polypharmacy.
What to Actually Do: Practical Actions and Red Flags
Seek emergency care immediately for any of the following red flags. Do not wait for a scheduled appointment.
- A seizure, especially a first-ever seizure during withdrawal
- Confusion, disorientation, or inability to state name, place, or time
- Heart rate above 120 beats per minute or blood pressure above 180/110
- Fever above 101°F (38.3°C) with agitation
- Visual or tactile hallucinations
- Vomiting that prevents oral fluid intake for more than 8 hours
For milder cases, concrete steps reduce risk. Do not stop abruptly if daily intake has been heavy and prolonged; seek medical tapering. Maintain hydration with electrolyte-containing fluids, not plain water alone. Eat carbohydrate-rich meals and take a thiamine supplement, since alcohol-related thiamine deficiency can precipitate Wernicke encephalopathy during withdrawal. Arrange a same-day check-in with a clinician if CIWA-Ar equivalent symptoms are moderate. Avoid caffeine and stimulants, which amplify tachycardia.
Limitations of Current Evidence
Protocols differ between institutions, and the CIWA-Ar was validated in hospitalized patients, not in home settings. Outpatient symptom-triggered dosing has support but relies on reliable self-reporting. The exact contribution of kindling to long-term relapse risk remains an active research question, and no biomarker currently predicts who will progress to DTs. Treat the numbers in this article as population ranges; individual trajectories vary, and clinical judgment remains the deciding factor.